Octreotide Efficacy and Safety in First-line Acromegalic Patients

This study has suspended participant recruitment.
Sponsor:
Information provided by:
Novartis
ClinicalTrials.gov Identifier:
NCT00171886
First received: September 13, 2005
Last updated: March 23, 2011
Last verified: March 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: No date given
  Primary Completion Date: May 2006 (Final data collection date for primary outcome measure)